Role of 18F-FDG-PET/CT in the staging of metastatic rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group
- 1 September 2021
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 155, 155-162
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparison of PET–CT and conventional imaging in staging pediatric rhabdomyosarcomaPediatric Blood & Cancer, 2012
- An evaluation of [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing SarcomaPediatric Blood & Cancer, 2012
- Positron Emission Tomography (PET) Evaluation After Initial Chemotherapy and Radiation Therapy Predicts Local Control in RhabdomyosarcomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- 18F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomasNuclear Medicine Communications, 2012
- [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformationJournal of Neuro-Oncology, 2012
- Additional Benefit of F-18 FDG PET/CT in the Staging and Follow-up of Pediatric RhabdomyosarcomaClinical Nuclear Medicine, 2011
- Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcomaAnnals of Nuclear Medicine, 2009
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative GroupsJournal of Clinical Oncology, 2008
- Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter TrialJournal of Clinical Oncology, 2007
- PET for Staging in Rhabdomyosarcoma: An Evaluation of PET as an Adjunct to Current Staging ToolsJournal of Pediatric Hematology/Oncology, 2007